Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/772
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMAGALHAES, Francisco N. De Oliveira-
dc.contributor.authorDOTTA, Luciana-
dc.contributor.authorSASSE, Andre-
dc.contributor.authorTEIXEIRA, Manoel J.-
dc.contributor.authorFONOFF, Erich T.-
dc.date.accessioned2013-07-30T15:08:20Z-
dc.date.available2013-07-30T15:08:20Z-
dc.date.issued2012-
dc.identifier.citationPAIN PHYSICIAN, v.15, n.2, p.E115-E129, 2012-
dc.identifier.issn1533-3159-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/772-
dc.description.abstractBackground: Low back pain (LBP) is one of the most common and important health problems affecting the population worldwide and remains mostly unsolved. Ozone therapy has emerged as an additional treatment method. Questions persist concerning its clinical efficacy. Objective: The purpose of our study was to evaluate the therapeutic results of percutaneous injection of ozone for low back pain secondary to disc herniation. Study Design: A systematic review and meta-analysis of randomized controlled trials. Methods: A comprehensive literature search was conducted using all electronic databases from 1966 through September 2011. The quality of individual articles was assessed based on the modified Cochrane review criteria for randomized trials and criteria from the Agency for Healthcare Research and Quality. Outcome Parameters: The outcome measure was short-term pain relief of at least 6 months or long-term pain relief of more than 6 months. Results: Eight observational studies were included in the systematic review and 4 randomized trials in the meta-analysis. The indicated level of evidence for long-term pain relief was II-3 for ozone therapy applied intradiscally and II-1 for ozone therapy applied paravertebrally. The grading of recommendation was 1C for intradiscal ozone therapy and 1B for paravertebral ozone therapy. Limitations: The main limitations of this review are the lack of precise diagnosis and the frequent use of mixed therapeutic agents. The meta-analysis included mainly active-control trials. No placebo-controlled trial was found. Conclusions: Ozone therapy appears to yield positive results and low morbidity rates when applied percutaneously for the treatment of chronic low back pain.-
dc.description.sponsorshipFAPESP [2011/08529-5]-
dc.language.isoeng-
dc.publisherAM SOC INTERVENTIONAL PAIN PHYSICIANS-
dc.relation.ispartofPain Physician-
dc.rightsopenAccess-
dc.subjectLow back pain-
dc.subjectozone therapy-
dc.subjectchronic pain-
dc.subjectfailed back surgery syndrome-
dc.subject.otheroxygen-ozone-
dc.subject.otherlumbar disc-
dc.subject.otherintraforaminal o-2-o-3-
dc.subject.otherinjection-
dc.subject.otherguidelines-
dc.subject.othersciatica-
dc.subject.othermanagement-
dc.titleOzone Therapy as a Treatment for Low Back Pain Secondary to Herniated Disc: A Systematic Review and Meta-analysis of Randomized Controlled Trials-
dc.typearticle-
dc.rights.holderCopyright AM SOC INTERVENTIONAL PAIN PHYSICIANS-
dc.identifier.pmid22430658-
dc.subject.wosClinical Neurology-
dc.type.categoryreview-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpageE115-
hcfmusp.description.endpageE129-
hcfmusp.description.issue2-
hcfmusp.description.volume15-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84859120791-
hcfmusp.origem.idWOS:000301917800001-
hcfmusp.publisher.cityPADUCAH-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceAndreula CF, 2003, AM J NEURORADIOL, V24, P996-
hcfmusp.relation.referenceAnsede Alonso JC, 2007, PATOLOGIA APARATO LO, V5, P46-
hcfmusp.relation.referenceBerg AO, 2001, AM J PREV MED, V20, P21-
hcfmusp.relation.referenceBocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006-
hcfmusp.relation.referenceBonetti M, 2005, AM J NEURORADIOL, V26, P996-
hcfmusp.relation.referenceBuric J, 2005, ACT NEUR S, V92, P93-
hcfmusp.relation.referenceChalaupka FD, 2007, HEADACHE, V47, P293-
hcfmusp.relation.referenceCohen SP, 2005, J SPINAL DISORD TECH, V18, pS119, DOI 10.1097/01.bsd.0000127823.54485.3f-
hcfmusp.relation.referenceCorea Francesco, 2004, J Stroke Cerebrovasc Dis, V13, P259, DOI 10.1016/j.jstrokecerebrovasdis.2004.08.004-
hcfmusp.relation.referenceFreynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488-
hcfmusp.relation.referenceGallucci M, 2007, RADIOLOGY, V242, P907, DOI 10.1148/radiol.2423051934-
hcfmusp.relation.referenceGautam S, 2011, PAIN PRACT, V11, P160, DOI 10.1111/j.1533-2500.2010.00409.x-
hcfmusp.relation.referenceGazzeri R, 2007, SPINE, V32, P121-
hcfmusp.relation.referenceGinanneschi F, 2006, SURG NEUROL, V66, P619, DOI 10.1016/j.surneu.2006.01.025-
hcfmusp.relation.referenceGiudice GL, 2004, AM J OPHTHALMOL, V138, P175-
hcfmusp.relation.referenceGuyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174-
hcfmusp.relation.referenceKaki AME-YAZ, 2005, REG ANESTH PAIN MED, V30, p422e1-
hcfmusp.relation.referenceKoes BW, 1995, PAIN, V63, P279, DOI 10.1016/0304-3959(95)00124-7-
hcfmusp.relation.referenceManchikanti L, 2009, PAIN PHYSICIAN, V12, P699-
hcfmusp.relation.referenceManchikanti L, 2009, PAIN PHYSICIAN, V12, P35-
hcfmusp.relation.referenceMoher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097-
hcfmusp.relation.referenceMuto M, 2004, J NEURORADIOLOGY, V31, P183, DOI 10.1016/S0150-9861(04)96989-1-
hcfmusp.relation.referenceMuto M, 1998, INTERV NEURORADIOL, V4, P279-
hcfmusp.relation.referenceMuto M, 2008, RADIOL MED, V113, P695, DOI 10.1007/s11547-008-0302-5-
hcfmusp.relation.referenceOder B, 2008, NEURORADIOLOGY, V50, P777, DOI 10.1007/s00234-008-0398-2-
hcfmusp.relation.referencePaoloni M, 2009, SPINE, V34, P1337, DOI 10.1097/BRS.0b013e3181a3c18d-
hcfmusp.relation.referencePostacchini F, 2011, ACTA NEUROCHIR SUPPL, V108, P17, DOI 10.1007/978-3-211-99370-5_4-
hcfmusp.relation.referenceStaal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558-
hcfmusp.relation.referenceWest S, 2002, EVID REP TECHNOL ASS, V47, P1-
hcfmusp.relation.referenceWu ZQ, 2009, EUR J RADIOL, V72, P499, DOI 10.1016/j.ejrad.2008.07.029-
hcfmusp.relation.referenceXu L, 2009, INTERV NEURORADIOL, V15, P159-
hcfmusp.relation.referenceZambello A, 2006, RIV NEURORADIOL, V5, P123-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.citation.scopus95-
hcfmusp.scopus.lastupdate2022-05-20-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MNE
Departamento de Neurologia - FM/MNE

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/IOT
Instituto de Ortopedia e Traumatologia - HC/IOT

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/26
LIM/26 - Laboratório de Pesquisa em Cirurgia Experimental


Files in This Item:
File Description SizeFormat 
art_MAGALHAES_Ozone_Therapy_as_a_Treatment_for_Low_Back_2012.PDFpublishedVersion (English)380.42 kBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.